| Subject |
Clarification on the media report with regards to the registration approval on Fespixon by Malaysia MOH |
- Date of occurrence of the event:2023/07/08
- Company name: Oneness Biotech Co., Ltd.
- Relationship to the Company (please enter ”head office” or ”subsidiaries”): head office
- Reciprocal shareholding ratios:NA
- Name of the reporting media:Sin Chew Daily news dated Jul 8th 2023
- Content of the report:News article titled: The registration of the first natural products with therapeutic claim – Fespixon has been approved. The news written “The Malaysian MOH has approved the registration of Fespixon as the first natural products with therapeutic claim, ....ensuring the well-being of consumers.”
- Cause of occurrence:Clarification on the media report.
- Countermeasures:Oneness has not received any written notification by Malaysian MOH or NPRA on Fespixon registration approval. Oneness will issue public announcement upon receipt of the Malaysian health authority’s official registration decision letter.
- Any other matters that need to be specified:
the new report links :
(1)https://www.thestar.com.my/news/nation/2023/07/08/health-ministry-approves-the-first-natural-products-with-therapeutic-claims-says-health-dg
(2)https://www.sinchew.com.my/?p=4812204
|
